Key result
Myocardial ischemia-reperfusion reduces infarct size ~36% versus unreperfused MI, limiting LV dilation without preserving function.
Why the study?
Most animal MI models rely on permanent coronary ligation in healthy mice, failing to reflect clinical reperfusion by primary PCI and contributing to translational failures.
Does myocardial ischemia-reperfusion injury compared to unreperfused myocardial infarction alter cardiac function, remodeling, and inflammation in hypercholesterolemic APOE*3-Leiden mice?
Does myocardial ischemia-reperfusion injury compared to unreperfused myocardial infarction alter cardiac function, remodeling, and inflammation in hypercholesterolemic APOE*3-Leiden mice?
The MI-R model in hypercholesterolemic mice more accurately resembles contemporary clinical outcomes of primary PCI by showing reduced infarct size and restricted LV remodeling compared to permanent ligation, providing a more translatable model for preclinical therapies.
Answers are grounded in this paper and cite their sources.
Supports reperfusion models for hypercholesterolemic mouse studies; leaves open clinical translation to primary PCI outcomes.
Many novel therapies to treat myocardial infarction (MI), yielding promising results in animal models, nowadays failed in clinical trials for several reasons. The most used animal MI model is based on permanent ligation of the left anterior descending (LAD) coronary artery in healthy mice resulting in transmural MI, while in clinical practice reperfusion is usually accomplished by primary percutaneous coronary interventions (PCI) limiting myocardial damage and inducing myocardial ischemia-reperfusion (MI-R) injury. To evaluate a more similar murine MI model we compared MI-R injury to unreperfused MI in hypercholesterolemic apolipoprotein (APO)E*3-Leiden mice regarding effects on cardiac function, left ventricular (LV) remodeling and inflammation. Both MI-R and MI resulted in significant LV dilation and impaired cardiac function after 3 weeks. Although LV dilation, displayed by end-diastolic (EDV) and end-systolic volumes (ESV), and infarct size (IS) were restricted following MI-R compared to MI (respectively by 27.6% for EDV, 39.5% ESV, 36.0% IS), cardiac function was not preserved. LV-wall thinning was limited with non-transmural LV fibrosis in the MI-R group (66.7%). Two days after inducing myocardial ischemia, local leucocyte infiltration in the infarct area was decreased following MI-R compared to MI (36.6%), whereas systemic circulating monocytes were increased in both groups compared to sham (130.0% following MI-R and 120.0% after MI). Both MI-R and MI models against the background of a hypercholesterolemic phenotype appear validated experimental models, however reduced infarct size, restricted LV remodeling as well as a different distributed inflammatory response following MI-R resemble the contemporary clinical outcome regarding primary PCI more accurately which potentially provides better predictive value of experimental therapies in successive clinical trials.
No takes yet. Share an insight, caveat, or question.
Pluijmert et al. (2020) studied Myocardial Infarction (n=63). Myocardial ischemia-reperfusion (MI-R) injury vs. Unreperfused myocardial infarction (MI) (permanent LAD ligation) was evaluated on Infarct size at 3 weeks assessed by contrast-enhanced MRI (%) (p=0.008). Myocardial ischemia-reperfusion restricted infarct size to 18.3% compared to 28.6% in unreperfused myocardial infarction, limiting left ventricular dilation without preserving cardiac function.
Synapse has enriched 10 related papers. Consider them for comparative context: